Mary Whittenhall
Overview
Explore the profile of Mary Whittenhall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh N, Eickhoff C, Garcia-Agundez A, Bertone P, Paudel S, Tambe D, et al.
Sci Rep
. 2023 Dec;
13(1):22534.
PMID: 38110438
Pulmonary arterial hypertension (PAH) is characterized by endothelial cell (EC) dysfunction. There are no data from living patients to inform whether differential gene expression of pulmonary artery ECs (PAECs) can...
2.
Walsh T, Baird G, Atalay M, Agarwal S, Arcuri D, Klinger J, et al.
Pulm Circ
. 2021 Jun;
11(2):2045894021989554.
PMID: 34094503
Pulmonary arterial hypertension (PAH) remains life-limiting despite numerous approved vasodilator therapies. Right ventricular (RV) function determines outcome in PAH but no treatments directly target RV adaptation. PAH is more common...
3.
Baird G, Walsh T, Aliotta J, Allahua M, Andrew R, Bourjeily G, et al.
Ann Am Thorac Soc
. 2020 Sep;
18(2):218-228.
PMID: 32885987
Sex hormones play a role in pulmonary arterial hypertension (PAH), but the menstrual cycle has never been studied. We conducted a prospective observational study of eight women with stable PAH...
4.
Amass T, Cumplido J, Aswad B, Whittenhall M, Ventetuolo C, Klinger J
Pulm Circ
. 2020 Apr;
10(1):2045894020907871.
PMID: 32284846
Intravascular foreign body deposition in the form of talc or microcrystalline cellulose is an uncommon but increasing cause of pulmonary hypertension given the current opioid epidemic. Earlier cases describe the...
5.
Banerjee D, Grammatopoulos T, Palmisciano A, Klinger J, Krishnan I, Whittenhall M, et al.
Chest
. 2020 Mar;
158(2):735-738.
PMID: 32112775
No abstract available.
6.
Ventetuolo C, Aliotta J, Braza J, Chichger H, Dooner M, McGuirl D, et al.
Eur Respir J
. 2020 Jan;
55(3).
PMID: 31949110
Endothelial dysfunction is a hallmark of pulmonary arterial hypertension (PAH) but there are no established methods to study pulmonary artery endothelial cells (PAECs) from living patients. We sought to culture...
7.
Baird G, Archer-Chicko C, Barr R, Bluemke D, Foderaro A, Fritz J, et al.
Eur Respir J
. 2018 Jun;
51(6).
PMID: 29954925
High oestradiol (E2) and low dehydroepiandrosterone-sulfate (DHEA-S) levels are risk factors for pulmonary arterial hypertension (PAH) in men, but whether sex hormones are related to PAH in women is unknown.Post-menopausal...
8.
Banerjee D, Kamuren J, Baird G, Palmisciano A, Krishnan I, Whittenhall M, et al.
Pulm Circ
. 2017 Jun;
7(2):384-390.
PMID: 28597751
Background Breathlessness is the most common symptom reported by patients with pulmonary arterial hypertension (PAH). The Modified Borg Dyspnea Scale (MBS) is routinely obtained during the six-minute walk test in...